• Users Online: 2
  • Print this page
  • Email this page
This article has been cited by
1EARLY PRESENTATION OF LESS COMMON ASSOCIATION- SYSTEMIC SCLEROSIS WITH APLA
Kalinga Bommanakatte Eranaik,Uday Subhas Bande,Basavaraj Devendrappa Baligar,Varun Bhaktarahalli Renukappa,Amogh Laxman Jambagi
Journal of Evidence Based Medicine and Healthcare.2017;4(51)3165
[DOI]
2Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis
Yu Pei Chock,Thomas Moulinet,Virginie Dufrost,Doruk Erkan,Denis Wahl,Stéphane Zuily
Autoimmunity Reviews.2019;18(11)102395
[DOI]
3Approaches to Microthrombotic Wounds
Asfandyar Mufti,Khalad Maliyar,Maleeha Syed,Christian Pagnoux,Afsaneh Alavi
Advances in Skin & Wound Care.2020;33(2)68
[DOI]
4Síndrome antifosfolípido
C. Sobrino Grande,L. Villalobos Sánchez,M. Valero Expósito,M.J. García Villanueva
Medicine - Programa de Formación Médica Continuada Acreditado.2017;12(27)1551
[DOI]
5One-decade study of distinct features, morbidity and mortality of systemic lupus erythematosus (an update on systemic lupus erythematosus in the Fars Province of Iran)
E Esmaeilzadeh,Z Khodamoradi,M A Nazarinia
Lupus.2019;28(11)1360
[DOI]
6The antiphospholipid syndrome: from pathophysiology to treatment
Simone Negrini,Fabrizio Pappalardo,Giuseppe Murdaca,Francesco Indiveri,Francesco Puppo
Clinical and Experimental Medicine.2017;17(3)257
[DOI]
  Feedback 
  Subscribe 
  Search 
  Advanced Search 
  Apply as Reviewer